Infosys (NSE: INFY), (BSE: INFY), , a global leader in next-generation digital services and consulting, delivered $5,099 million in Q3 revenues, year on year growth of 1.7% and sequential growth of 0.
News Medical on MSN
Lund researchers create "recipe book" for reprogramming immune cells to fight disease
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback